skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples

Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases

Inês Sousa-lima ; Hyun Jeong Kim ; John Jones ; Young-bum Kim

Diabetes & metabolism journal, 2021-09, Vol.45 (5), p.655-674 [Periódico revisado por pares]

대한당뇨병학회

Texto completo disponível

Citações Citado por
  • Título:
    Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
  • Autor: Inês Sousa-lima ; Hyun Jeong Kim ; John Jones ; Young-bum Kim
  • Assuntos: AMP-activated protein kinase ; Diet ; high-fat ; Lipogenesis ; Nonalcoholic fatty liver disease ; Rho-kinase
  • É parte de: Diabetes & metabolism journal, 2021-09, Vol.45 (5), p.655-674
  • Notas: Korean Diabetes Association
  • Descrição: Nonalcoholic fatty liver disease (NAFLD) is a major public health problem and the most common form of chronic liver disease, affecting 25% of the global population. Although NAFLD is closely linked with obesity, insulin resistance, and type 2 diabetes mellitus, knowledge on its pathogenesis remains incomplete. Emerging data have underscored the importance of Rho-kinase (Rho-associated coiled-coil-containing kinase [ROCK]) action in the maintenance of normal hepatic lipid homeostasis. In particular, pharmacological blockade of ROCK in hepatocytes or hepatic stellate cells prevents the progression of liver diseases such as NAFLD and fibrosis. Moreover, mice lacking hepatic ROCK1 are protected against obesity-induced fatty liver diseases by suppressing hepatic de novo lipogenesis. Here we review the roles of ROCK as an indispensable regulator of obesity-induced fatty liver disease and highlight the key cellular pathway governing hepatic lipid accumulation, with focus on de novo lipogenesis and its impact on therapeutic potential. Consequently, a comprehensive understanding of the metabolic milieu linking to liver dysfunction triggered by ROCK activation may help identify new targets for treating fatty liver diseases such as NAFLD.
  • Editor: 대한당뇨병학회
  • Idioma: Coreano
Voltar para lista de resultados
Ir para página anteriorAnterior Resultado  8 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.